Prediagnostic alcohol consumption and colorectal cancer survival: The Colon Cancer Family Registry.
Prediagnostic alcohol consumption and colorectal cancer survival: The Colon Cancer Family Registry.
复制标题
DOI:
10.1002/cncr.30446
复制
发表时间:
2017-05-15
期刊:
影响因子:
6.2
通讯作者:
Newcomb PA
中科院分区:
文献类型:
--
作者:
Phipps AI;Robinson JR;Campbell PT;Win AK;Figueiredo JC;Lindor NM;Newcomb PA
Although previous studies have noted an increased risk of colorectal cancer (CRC) among moderate to heavy alcohol consumers relative to non-drinkers, the relationship between alcohol consumption and CRC survival remains unclear. Cases of incident invasive CRC diagnosed between 1997-2007 were identified via population-based cancer registries at four study sites in the Colon Cancer Family Registry. Study participants completed a risk factor questionnaire on pre-diagnostic behaviors, including wine, beer, and liquor consumption, at baseline. Prospective follow-up for survival was conducted for 4966 CRC cases. Using Cox regression, we compared non-drinkers to individuals who consumed, on average, ≥1 serving/day of alcohol in the years preceding CRC diagnosis with respect to overall and disease-specific survival. Separate analyses by beverage type, and stratified by patient and tumor attributes, were also performed. All models were adjusted for age at diagnosis, sex, study site, year of diagnosis, smoking history, body mass index, and education. Pre-diagnostic beer and liquor consumption were not associated with CRC survival; however, higher levels of wine consumption were modestly associated with better prognosis overall [hazard ratio (HR)CRC-specific=0.70, 95% confidence interval (CI): 0.48-1.03 and HRoverall=0.70, 95% CI: 0.53-0.94). Similar patterns were noted in stratified analyses. These findings suggest that pre-diagnostic wine consumption is modestly associated with more favorable survival after CRC.